Join the Heart Attack group to help and get support from people like you.
Heart Attack News (Page 5)
Victoza (liraglutide) is Approved to Reduce the Risk of Three Major Adverse Cardiovascular Events in Type 2 Diabetes Patients
PLAINSBORO, N.J., Aug. 25, 2017 /PRNewswire/ – The U.S. Food and Drug Administration (FDA) has approved a new indication for Victoza (liraglutide) to reduce the risk of major adverse cardiovascular...
FDA Approves Expanded Indication for Brilinta to Include Long-Term Use in Patients with a History of Heart Attack
Thursday, 3 September 2015 – AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved Brilinta (ticagrelor) tablets at a new 60mg dose to be used in patients with a...
FDA Approves Zontivity to Reduce the Risk of Heart Attacks and Stroke
May 8, 2014 – The U.S. Food and Drug Administration today approved Zontivity (vorapaxar) tablets to reduce the risk of heart attack, stroke, cardiovascular death, and need for procedures to restore...
FDA Medwatch Alert: Nitroglycerin in 5% Dextrose Injection by Baxter: Recall - Particulate Matter
ISSUE: Baxter International Inc has initiated a voluntary recall of one lot of Nitroglycerin in 5% Dextrose Injection due to particulate matter found in one vial. If infused, particulate matter could...
Ask a question
To post your own question to this support group, sign in or create an account.
Further information
Related drug support groups
lisinopril, metoprolol, aspirin, propranolol, warfarin, Plavix, atenolol, Coumadin, Metoprolol Succinate ER, view more... clopidogrel, Metoprolol Tartrate, Brilinta, valsartan, Lovenox, ramipril, Arthritis Pain, Diovan, ticagrelor, nitroglycerin